| Christie J Prestifilippo, MD | |
|
19 E Main St, Mendham, NJ 07945-1503 | |
| (973) 543-6505 | |
| (973) 543-2967 |
| Full Name | Christie J Prestifilippo |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 19 E Main St, Mendham, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336129931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MA71130 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlantic Home Care & Hospice | Morristown, NJ | Home health agency |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Mendham Llc | 2567707995 | 2 |
News Archive
Juventas Therapeutics, Inc., a clinical-stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body, today announced that its product candidate, JVS-100, received Fast Track designation from the U.S. Food and Drug Administration for the treatment of advanced ischemic chronic heart failure.
MasterCard Worldwide recently partnered with Interpol to support the global police organization's efforts to prevent websites from supplying illegal and counterfeit prescription drugs and medicines to consumers. Named "Operation Pangea III," the week-long effort covered 45 participating countries and resulted in 76 arrests to date. Additionally, 290 websites have been shut down and nearly 11,000 packages of contraband have been seized or detained.
An extraordinary gift of $5 million from Mr. G. Raymond Chang, Chancellor of Ryerson University and Chair of CI Financial, will go toward furthering research and education about the treatment of mental health and addictions, the Centre for Addiction and Mental Health (CAMH) Foundation announced today.
Bristol-Myers Squibb Company, and AstraZeneca today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States.
Like nearly 4.6 million Americans, ancient hunter-gatherers also suffered from clogged arteries, revealing that the plaque build-up causing blood clots, heart attacks and strokes is not just a result of fatty diets or couch potato habits, according to new research in the journal The Lancet.
› Verified 8 days ago
| Entity Name | Medical Associates Of Mendham Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457836363 PECOS PAC ID: 2567707995 Enrollment ID: O20181213000089 |
News Archive
Juventas Therapeutics, Inc., a clinical-stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body, today announced that its product candidate, JVS-100, received Fast Track designation from the U.S. Food and Drug Administration for the treatment of advanced ischemic chronic heart failure.
MasterCard Worldwide recently partnered with Interpol to support the global police organization's efforts to prevent websites from supplying illegal and counterfeit prescription drugs and medicines to consumers. Named "Operation Pangea III," the week-long effort covered 45 participating countries and resulted in 76 arrests to date. Additionally, 290 websites have been shut down and nearly 11,000 packages of contraband have been seized or detained.
An extraordinary gift of $5 million from Mr. G. Raymond Chang, Chancellor of Ryerson University and Chair of CI Financial, will go toward furthering research and education about the treatment of mental health and addictions, the Centre for Addiction and Mental Health (CAMH) Foundation announced today.
Bristol-Myers Squibb Company, and AstraZeneca today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States.
Like nearly 4.6 million Americans, ancient hunter-gatherers also suffered from clogged arteries, revealing that the plaque build-up causing blood clots, heart attacks and strokes is not just a result of fatty diets or couch potato habits, according to new research in the journal The Lancet.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christie J Prestifilippo, MD 19 E Main St, Mendham, NJ 07945-1503 Ph: (973) 543-6505 | Christie J Prestifilippo, MD 19 E Main St, Mendham, NJ 07945-1503 Ph: (973) 543-6505 |
News Archive
Juventas Therapeutics, Inc., a clinical-stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body, today announced that its product candidate, JVS-100, received Fast Track designation from the U.S. Food and Drug Administration for the treatment of advanced ischemic chronic heart failure.
MasterCard Worldwide recently partnered with Interpol to support the global police organization's efforts to prevent websites from supplying illegal and counterfeit prescription drugs and medicines to consumers. Named "Operation Pangea III," the week-long effort covered 45 participating countries and resulted in 76 arrests to date. Additionally, 290 websites have been shut down and nearly 11,000 packages of contraband have been seized or detained.
An extraordinary gift of $5 million from Mr. G. Raymond Chang, Chancellor of Ryerson University and Chair of CI Financial, will go toward furthering research and education about the treatment of mental health and addictions, the Centre for Addiction and Mental Health (CAMH) Foundation announced today.
Bristol-Myers Squibb Company, and AstraZeneca today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States.
Like nearly 4.6 million Americans, ancient hunter-gatherers also suffered from clogged arteries, revealing that the plaque build-up causing blood clots, heart attacks and strokes is not just a result of fatty diets or couch potato habits, according to new research in the journal The Lancet.
› Verified 8 days ago
Frantz Junior M. Pierre-louis, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9 Burnett Rd, Mendham, NJ 07945 Phone: 347-232-7297 | |
Matthew Schaikewitz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Tempe Wick Rd, Mendham, NJ 07945 Phone: 973-543-2288 | |
Dr. Sandy A Furey Iii, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8 Horizon Dr, Mendham, NJ 07945 Phone: 973-543-4220 | |
James Henry Wolf, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 19 E Main St, Mendham, NJ 07945 Phone: 973-543-6505 Fax: 973-543-2967 | |
Daniel Robert Amoruso, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Tempe Wick Rd Ste 300, Mendham, NJ 07945 Phone: 973-543-2288 | |
Allison Carthan Connolly, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 E Main St, Mendham, NJ 07945 Phone: 973-543-6599 |